HOME >> MEDICINE >> NEWS
New Drug Prevents Breast Cancer In Postmenopausal Women, UCSF Researchers Report

LOS ANGELES -- Researchers at the University of California San Francisco report that a novel hormone therapy drug reduces the risk of breast cancer in women by 70 percent.

"Our findings are very exciting because they show that it may be possible to prevent breast cancer in postmenopausal women who have no prior history of the disease," says Steven Cummings, MD, UCSF professor of medicine and epidemiology and lead author of the study.

Cummings presented his findings today (May 18) at the annual meeting of the American Society of Clinical Oncology.

UCSF researchers found that the osteoporosis prevention drug, raloxifene, drastically reduced the risk of breast cancer in postmenopausal women without indicating an increased risk of endometrial, or uterine cancer. Other drugs in raloxifene's class, including tamoxifen, have been shown to increase the risk of endometrial cancer in women.

Although tamoxifen was recently reported to reduce the risk of breast cancer in women who are at high risk of the disease by 45 percent, it also showed an increased risk of endometrial cancer. Of the 13,388 women who participated in the tamoxifen study, 33 of those who received the drug developed endometrial cancer, compared to 14 of the women assigned to placebo. Raloxifene and tamoxifen belong to a class of drugs called selective estrogen receptor modulators (SERMS), which block the actions of estrogen in some tissues, such as the breasts, and mimic estrogen in other tissues, such as the bones.

"During the clinical trials of raloxifene, we saw twice as many cases of breast cancer develop among women taking placebo compared to those taking raloxifene," Cummings says.

After an average of 33 months, 32 cases of breast cancer developed in the women who participated in the study. While 21 or .82 percent of the women who were given placebo developed breast cancer, only 11 or .21 percent of those assigned to raloxifene developed the disease. However, like tamoxif
'"/>

Contact: Abby Sinnott
sinnott@itsa.ucsf.edu
(415) 885-7277
University of California - San Francisco
18-May-1998


Page: 1 2 3

Related medicine news :

1. New Chest Pain Evaluation Method Saves Lives, Prevents Costly HospitalizationFor Some Patients
2. Physicians Study Whether "Super-Aspirin" Prevents Alzheimers
3. Treatment Of Irregular Heartbeat Saves Money And Prevents Stroke In Older People
4. Drug Prevents Hearing Loss Caused By Brain Tumor Therapy
5. Compound In Meat Prevents Diabetes, Study Suggests
6. Hausman to give keynote address at Breastfeeding, Motherhood and Feminism symposium
7. Breast implant Website launched by leading plastic surgery societies
8. Breast cancer treatment reduces risk of heart disease
9. Breast reconstruction with implants after mastectomy doesnt hurt survival chances
10. Breast cancer may be uniquely sensitive to inhibitors of PI3K pathway
11. Breast MRI moderately useful for detecting breast cancer, but does not eliminate need for biopsy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/14/2019)... ... ... providers for May 2019. , FL TOP DOCS INCLUDE: , BARIATRIC MEDICINE/SURGERY, ... Berlin , CARDIOLOGY, Dr. Nirat Beohar , ... , DERMATOLOGY, Dr. B. Jennifer Berkes ...
(Date:6/13/2019)... DETROIT (PRWEB) , ... June 13, 2019 , ... Women’s Excellence in Obstetrics and Gynecology ... of conditions, some that may be difficult to diagnosis. Women’s Excellence handles routine and ... Ovarian cysts , Endometriosis , Heavy periods , Adhesions ...
(Date:6/13/2019)... ... ... Hard money lenders like Monroe Funding Corporation are able to respond and ... quickly. If the documentation and collateral are immediately available, it’s possible to receive approval ... involved with a traditional lender, which allows loans to be customized and adjusted based ...
(Date:6/13/2019)... ... June 13, 2019 , ... Clinical Ink , a global clinical ... that Jonathan Andrus , chief business officer at Clinical Ink, has been invited ... for Health Policy on July 1, 2019, in Washington, D.C. The workshop, convened ...
(Date:6/13/2019)... (PRWEB) , ... June 13, 2019 , ... ... Morgan, RN, BSN, CRNI and Charles “Charlie” Schadewald as the newest members of ... served as members of NICA’s Advisory Committee. The NICA Advisory Committee is comprised ...
Breaking Medicine News(10 mins):
(Date:6/11/2019)... ... June 11, 2019 , ... Today NASH ... as a precursor to International Nonalcoholic Steatohepatitis (NASH) Day, a global effort in ... next looming public health crisis and what they can do to help. The ...
(Date:6/11/2019)... , ... June 11, 2019 ... ... in delivering optimal cost, quality and clinical outcomes, today announced the latest ... application is now available to current and prospective customers. , “We ...
(Date:6/6/2019)... Calif. (PRWEB) , ... June 06, 2019 , ... MEDICC ... further curtail US travel to Cuba. “This latest move is one more assault on ... island,” said Dr. Peter G. Bourne, Chair of MEDICC’s Board of Directors. , ...
Breaking Medicine Technology:
Cached News: